Jupiter Life Line Hospitals Ltd

Jupiter Life Lin Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Jupiter Life Line Hospitals Ltd

₹ 1,526 -0.71%
09 Oct 10:27 a.m.
jupiterhospital.com BSE: 543980 NSE: JLHL
About

Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]

Key Points

Hospital Portfolio[1][2]
The company operates 3 hospitals with 1,275 Doctors across:
a) Thane - 377 Operating Beds and 72.1% Average Occupancy
b) Pune - 309 Operating Beds and 54.9% Average Occupancy
c) Indore - 375 Operating Beds and 65.5% Average Occupancy

Website BSE NSE
  • Market Cap ₹ 10,004 Cr.
  • Current Price ₹ 1,526
  • High / Low ₹ 1,770 / 1,250
  • Stock P/E 53.4
  • Book Value ₹ 217
  • Dividend Yield 0.07 %
  • ROCE 17.7 %
  • ROE 13.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 43.4% CAGR over last 5 years

Cons

  • Stock is trading at 7.09 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
179 198 200 210 208 227 230 246 241 273 270 274 278
130 141 154 158 157 168 173 189 184 204 202 202 210
Operating Profit 49 57 46 52 51 59 57 57 57 69 69 72 68
OPM % 27% 29% 23% 25% 25% 26% 25% 23% 24% 25% 25% 26% 24%
2 2 2 4 5 5 8 10 7 9 7 7 13
Interest 7 7 7 7 8 9 1 1 1 1 3 4 3
Depreciation 7 7 7 7 8 8 8 7 8 10 11 13 17
Profit before tax 37 46 34 42 41 48 56 59 55 67 62 62 61
Tax % 0% 21% 79% 36% 25% 25% 25% 27% 26% 25% 21% 28% 29%
37 36 7 27 30 36 42 43 41 50 49 44 43
EPS in Rs 7.31 7.10 1.28 4.73 5.39 5.51 6.44 6.58 6.20 7.67 7.52 6.78 6.60
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
320 398 463 461 657 787 915 1,060 1,095
266 333 380 392 498 583 687 791 817
Operating Profit 54 65 83 69 159 204 227 269 278
OPM % 17% 16% 18% 15% 24% 26% 25% 25% 25%
5 2 2 4 4 11 26 28 36
Interest 16 24 26 28 29 28 19 9 11
Depreciation 20 24 26 27 28 29 31 42 51
Profit before tax 24 20 33 18 106 159 204 246 252
Tax % -25% 8% 10% 5% 20% 33% 25% 25%
30 18 30 17 85 107 152 185 187
EPS in Rs 5.88 3.57 5.83 3.26 16.65 18.97 23.18 28.17 28.57
Dividend Payout % 8% 0% 0% 0% 0% 0% 4% 4%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 17%
TTM: 16%
Compounded Profit Growth
10 Years: %
5 Years: 43%
3 Years: 29%
TTM: 16%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 10%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 17%
Last Year: 13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 51 51 51 51 51 57 66 66
Reserves 147 162 186 202 278 409 1,180 1,357
210 252 263 262 322 298 0 142
63 71 94 100 104 123 115 145
Total Liabilities 470 537 594 615 755 885 1,361 1,710
379 431 435 426 465 476 477 713
CWIP 28 12 10 13 14 16 61 163
Investments 1 2 2 65 71 95 111 208
63 92 146 109 205 297 711 626
Total Assets 470 537 594 615 755 885 1,361 1,710

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
43 46 75 113 142 184 110 220
-43 -58 -43 -78 -68 -130 -238 -173
1 16 -32 -23 10 -23 122 302
Net Cash Flow 1 3 -1 12 84 31 -6 348

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 20 24 35 16 15 19 18 13
Inventory Days 60 46 64 45 38 42 39 35
Days Payable 224 168 268 192 155 169 116 157
Cash Conversion Cycle -144 -98 -169 -132 -101 -108 -59 -110
Working Capital Days 11 11 36 1 -18 -18 -7 -20
ROCE % 10% 12% 9% 23% 27% 22% 18%

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91%
4.62% 3.96% 4.17% 6.06% 8.84% 10.04% 10.04% 9.77%
12.69% 13.92% 14.16% 13.85% 13.46% 15.75% 15.64% 15.82%
41.80% 41.19% 40.76% 39.18% 36.79% 33.31% 33.43% 33.51%
No. of Shareholders 54,78239,34835,10735,79734,08133,91433,95634,192

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls